Research has shown that cancer cells are not all the same. Within a malignant tumor or among the circulating cancerous cells of a leukemia, there can be a variety of types of cells. The stem cell theory of cancer proposes that among all cancerous cells, a few act as stem cells that reproduce themselves and sustain the cancer, much like normal stem cells normally renew and sustain our organs and tissues. In this view, cancer cells that are not stem cells can cause problems, but they cannot sustain an attack on our bodies over the long term.
The idea that cancer is primarily driven by a smaller population of stem cells has important implications. For instance, many new anti-cancer therapies are evaluated based on their ability to shrink tumors, but if the therapies are not killing the cancer stem cells, the tumor will soon grow back (often with a vexing resistance to the previously used therapy). An analogy would be a weeding technique that is evaluated based on how low it can chop the weed stalksbut no matter how low the weeks are cut, if the roots arent taken out, the weeds will just grow back.
Another important implication is that it is the cancer stem cells that give rise to metastases (when cancer travels from one part of the body to another) and can also act as a reservoir of cancer cells that may cause a relapse after surgery, radiation or chemotherapy has eliminated all observable signs of a cancer.
One component of the cancer stem cell theory concerns how cancers arise. In order for a cell to become cancerous, it must undergo a significant number of essential changes in the DNA sequences that regulate the cell. Conventional cancer theory is that any cell in the body can undergo these changes and become a cancerous outlaw. But researchers at the Ludwig Center observe that our normal stem cells are the only cells that reproduce themselves and are therefore around long enough to accumulate all the necessary changes to produce cancer. The theory, therefore, is that cancer stem cells arise out of normal stem cells or the precursor cells that normal stem cells produce.
Thus, another important implication of the cancer stem cell theory is that cancer stem cells are closely related to normal stem cells and will share many of the behaviors and features of those normal stem cells. The other cancer cells produced by cancer stem cells should follow many of the rules observed by daughter cells in normal tissues. Some researchers say that cancerous cells are like a caricature of normal cells: they display many of the same features as normal tissues, but in a distorted way. If this is true, then we can use what we know about normal stem cells to identify and attack cancer stem cells and the malignant cells they produce. One recent success illustrating this approach is research on anti-CD47 therapy.
Next Section >> Case Study: Leukemia
Excerpt from:
The Stem Cell Theory of Cancer | Ludwig Center | Stanford ...
- By turning stem cells into brain cells, Aspen Neuroscience hopes to rewind the progress of Parkinson's disease - FierceBiotech - December 14th, 2019
- SelectScience Interview: Regenerative medicine technique development and the importance of cooperative research - SelectScience - December 14th, 2019
- Mechanism may have therapeutic bone healing applications - Baylor College of Medicine News - December 14th, 2019
- CHMP Grants Positive Opinion for Expanded Use of Darzalex (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for... - December 14th, 2019
- Mayo Clinic, maker of Gore-Tex outerwear are teaming up in Crohn's fight - Minneapolis Star Tribune - December 11th, 2019
- Proteostasis Therapeutics to Initiate First Ever Personalized Medicine-Based Clinical Trial, CHOICES, in European CF Patients with Genotypes... - December 11th, 2019
- Stem Cell and Regenerative Therapy Market 2019 By Global Industry Size, Share, Growth, Trends, Top Company Profiles and Future Analysis 2026 - Montana... - December 11th, 2019
- Blinatumomab Instead of Chemo in Young Patients With Relapsed ALL - Medscape - December 10th, 2019
- Fate Therapeutics Soars as Much as 45.8% After Giving Investors What They Wanted - The Motley Fool - December 10th, 2019
- FDA Warns Liveyon Over Cord Blood Stem Cell Products - MedPage Today - December 10th, 2019
- Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting - Business Wire - December 10th, 2019
- AgeX Therapeutics Issues Year-End Letter to Shareholders - BioSpace - December 10th, 2019
- Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting &... - December 10th, 2019
- The Uncertainty of Regulating 3D Organ Printing - The Regulatory Review - December 10th, 2019
- Top Florida Medical Spa, Amnion of Florida, Partners With Merakris Therapeutics to Advance Their Non-Surgical Treatment Options - Business Wire - December 10th, 2019
- Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency -... - December 10th, 2019
- Orchard Therapeutics Showcases Clinical Data at the 61st American Society of Hematology Annual Meeting - BioSpace - December 10th, 2019
- MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed Acute Myeloid Leukemia at the 2019 ASH Annual... - December 10th, 2019
- Olympic Hall of Fame Inductee Gary Hall Jr. Joins C3 International Board of Advisors - BioSpace - December 10th, 2019
- Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable - The Motley Fool - December 8th, 2019
- Jasper Therapeutics Raises $35M in Series A Financing - FinSMEs - December 8th, 2019
- Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes - OncoZine - December 8th, 2019
- Interview: Shaping the future - The Actuary - December 5th, 2019
- Cobalt Chloride Induced Apoptosis by Inhibiting GPC3 Expression via th | OTT - Dove Medical Press - December 5th, 2019
- First UK Clinical Trial Site Open for Recruitment of Diabetic Patients with Chronic Limb-Threatening Ischemia Using Novel Patient-Specific... - December 5th, 2019
- Medicine Against Bone Disease Found in the Leaves of Saussurea - Global Health News Wire - December 5th, 2019
- Will We Live to Age 120? International Expert Weighs in at Danbury Event - HamletHub - December 5th, 2019
- 100 hospitals and health systems with great orthopedic programs | 2019 - Becker's Hospital Review - December 5th, 2019
- Investigating the Human Intestinal Mucus Barrier Up-close and Personal - Technology Networks - December 5th, 2019
- Medicine of the future: cell technologies in Ukraine - Interfax-Ukraine - November 30th, 2019
- Stem Cell Therapy May Improve Heart Health In New Ways - TheHealthMania - November 30th, 2019
- Intermountain to open new center for pediatric precision medicine - Healthcare IT News - November 28th, 2019
- Homology Medicines Announces Peer-Reviewed Publication Demonstrating its AAVHSC Vectors Crossed the Blood-Brain-Barrier and Blood-Nerve-Barrier in... - November 28th, 2019
- Discover The Latest Frontier in Anti-aging Medicine and 3 Regenerative Therapies You Should Know... - YourObserver.com - November 28th, 2019
- Worldwide Markets for Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing, Forecast to 2030 - Robust Pipeline of Therapy Candidates and... - November 28th, 2019
- Health & Biotech: Mesoblast still not in the black, but theyre less in the red than last year - Stockhead - November 25th, 2019
- Regenerative Medicine Market: Rising Government Investments in Regenerative Medicine Research - The Chicago Sentinel - November 25th, 2019
- Visiongain Report Offers Transformative Insights on the $3.2bn Protein Expression Market - PRNewswire - November 25th, 2019
- Research Antibodies and Reagents Market Worth $14.56 Billion by 2025 - Exclusive Report by Meticulous Research - GlobeNewswire - November 25th, 2019
- Immune-Onc Therapeutics Prepares for its Next Phase of Growth with New Leadership Appointments and Key Board Member Additions - Business Wire - November 25th, 2019
- Breakthrough Discovery In Plants DNA May Lead To Slowing Aging Process In Humans - CBS Pittsburgh - November 24th, 2019
- Missing Link To Longevity Discovered In The Plant Kingdom - Texas A&M; University - November 24th, 2019
- Multiple Doses of Stem Cells Show Potential in Treating Severe Asthma - PR Web - November 21st, 2019
- Full Alliance Group Announces New EBO2 Sites in Florida and the Caribbean - P&T; Community - November 21st, 2019
- Vor Biopharma and MaxCyte Announce Clinical and Commercial License Agreement for Engineered Hematopoietic Stem Cells (eHSCs) to Treat Cancer | More... - November 21st, 2019
- Global Cell Separation Market 2020-2024 | Evolving Opportunities with Akadeum Life Sciences and Becton, Dickinson and Co. | Technavio - Business Wire - November 21st, 2019
- Growing at an Annualized Rate of Over 20%, The Cell Therapy Manufacturing Market is Estimated to Reach Close to USD 10 Billion by 2030, Claims Roots... - November 21st, 2019
- WCM-Q explores law and ethics of stem cells and AI in medicine - Gulf Times - November 17th, 2019
- Global Regenerative Medicine Market to Grow Over $81 Billion by 2023 and Market Driven by Stem Cells - PharmiWeb.com - November 17th, 2019
- New Invention of Artificial intelligence in Medicine with Stem Cells by WCM-Q - Universal News - November 17th, 2019
- Introducing the Targeted Anticancer Therapies and Precision Medicine in Cancer Collection - PLoS Blogs - November 17th, 2019
- How in utero Zika virus infection can lead to microcephaly in newborns: Baylor research - Outbreak News Today - November 17th, 2019
- The Global Trend to Trash Regulations and Rush Drugs to Market - PsychCentral.com - November 16th, 2019
- Stem Cell And Regenerative Therapy Market to witness a healthy growth by 2024 - Guru Online News - November 16th, 2019
- Works complete on ground-breaking medical research centre at University of Nottingham - East Midlands Business Link - November 16th, 2019
- ISSCA Faculty Honored with Health Sciences Awards at Conference Held at the University of Miami - PRUnderground - November 12th, 2019
- BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem Cell Meeting - GlobeNewswire - November 12th, 2019
- Learn How You Can Treat Your Pain with Regenerative Medicine! - Patch.com - November 12th, 2019
- New Drug Benefits Patients With Myeloma Who Are Resistant to All Therapies - Dana-Farber Cancer Institute - November 12th, 2019
- Notice of Business Alliance between Promethera Biosciences SA and MEDIPAL HOLDINGS - Business Wire - November 12th, 2019
- Silencing Of MAGI1 Promotes The Proliferation And Inhibits Apoptosis O | OTT - Dove Medical Press - November 12th, 2019
- Stem Cell Banking Market 2019: Growth, Trends, Demand, Share, Analysis and Forecast to 2026 - Markets Gazette 24 - November 12th, 2019
- 4th Annual Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress - Montana Ledger - November 12th, 2019
- Global Progenitor Cell-Based Market to Witness Robust Expansion throughout the Forecast 2026 - Herald Correspondent - November 11th, 2019
- Business Analytics of Regenerative Medicine Market to See Excellent Growth by 2026 |Popular Keysights: Organogenesis Inc., Vericel Corporation, Osiris... - November 11th, 2019
- Analysis of Regenerative Medicine Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to... - November 11th, 2019
- Sangamo Announces Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data Presentations at the American Society of Hematology Annual Meeting - Yahoo... - November 10th, 2019
- The final frontier? Studying stem cells on the International Space Station - Scope - November 8th, 2019
- Space travel affects heart cells, but only temporarily - BBC Focus Magazine - November 8th, 2019
- Super-grafts That Could Treat Diabetes - Technology Networks - November 8th, 2019
- Doheny and UCLA Stein Eye Institutes Welcome Kaustabh Ghosh, PhD, to the Scientific and Clinical Research Faculty - P&T; Community - November 3rd, 2019
- Neural Stem Cell Transplantation Crawls Toward the Clinic - The Scientist - October 31st, 2019
- Exosome Procedures Now Being Included With the R3 Stem Cell Regenerative Aesthetics Training Course - Yahoo Finance - October 31st, 2019
- New NCCN Guidelines Debut to Manage Complications and Improve Readiness for Stem Cell Transplant Recipients - P&T; Community - October 31st, 2019
- Briggs undergrad researcher wins award at international conference - MSUToday - October 31st, 2019
- Delivering the promise of regenerative medicine - PMLiVE - October 31st, 2019
- Further Debate on T3 + T4 Combination Therapy at ATA Meeting - Medscape - October 31st, 2019
- Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus - P&T; Community - October 31st, 2019
- Stem Cell And Regenerative Therapy Market Size by Type, Product, Application & Market Opportunities 2023 - Guru Online News - October 31st, 2019
- AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance... - October 31st, 2019
